Haage P, Vorwerk D, Piroth W, Schuermann K, Guenther R W
Department of Diagnostic Radiology, University of Technology, Aachen, Germany.
Radiology. 1999 Jul;212(1):175-80. doi: 10.1148/radiology.212.1.r99jl21175.
To analyze the effectiveness of stent placement as the primary treatment for central venous obstruction in patients undergoing hemodialysis.
Fifty-seven Wallstents were placed in 50 patients with symptomatic shunt dysfunction and arm swelling due to central venous obstruction. Technical success, complication, and patency rates were evaluated.
Stent deployment was successful in all patients, and early rethrombosis (within 1 week) was noted in one patient (2%). Seventy-three episodes of reobstruction occurred and were treated percutaneously with angioplasty alone in 54 cases (74%). Nineteen cases (26%) necessitated additional stent placement. The 3-, 6-, 12-, and 24-month primary patency rates were 92%, 84%, 56%, and 28%, respectively. Cumulative overall stent patency was 97% after 6 and 12 months, 89% after 24 months, and 81% after 36 and 48 months.
In the treatment of brachiocephalic and subclavian venous obstruction, stent placement shows excellent technical results and helps preserve vascular access for a substantial period. Multiple repeat interventions are, however, frequently required to maintain patency.
分析支架置入术作为血液透析患者中心静脉阻塞主要治疗方法的有效性。
对50例因中心静脉阻塞导致有症状的分流功能障碍和手臂肿胀的患者置入了57个Wallstent支架。评估技术成功率、并发症发生率和通畅率。
所有患者支架置入均成功,1例患者(2%)出现早期再血栓形成(1周内)。发生73次再阻塞事件,其中54例(74%)仅通过经皮血管成形术治疗。19例(26%)需要再次置入支架。3个月、6个月、12个月和24个月的原发性通畅率分别为92%、84%、56%和28%。6个月和12个月后累积总体支架通畅率为97%,24个月后为89%,36个月和48个月后为81%。
在治疗头臂静脉和锁骨下静脉阻塞时,支架置入术显示出良好的技术效果,并有助于在相当长的一段时间内保留血管通路。然而,为维持通畅,经常需要多次重复干预。